Acerus Pharmaceuticals (TSX:ASP) Days Payable : 1,146.73 (As of Sep. 2022)

View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Days Payable?

Acerus Pharmaceuticals's average Accounts Payable for the three months ended in Sep. 2022 was C$3.38 Mil. Acerus Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2022 was C$0.27 Mil. Hence, Acerus Pharmaceuticals's Days Payable for the three months ended in Sep. 2022 was 1,146.73.

The historical rank and industry rank for Acerus Pharmaceuticals's Days Payable or its related term are showing as below:

TSX:ASP's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 88.69
* Ranked among companies with meaningful Days Payable only.

Acerus Pharmaceuticals's Days Payable increased from Sep. 2021 (317.09) to Sep. 2022 (1,146.73). It may suggest that Acerus Pharmaceuticals delayed paying its suppliers.

Acerus Pharmaceuticals Days Payable Historical Data

The historical data trend for Acerus Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals Days Payable Chart

Acerus Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Payable

Get a 7-Day Free Trial

135.68

44.73

200.65

192.90

679.37

Acerus Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Days Payable	Get a 7-Day Free Trial															317.09	614.35	1,129.72	563.05	1,146.73

Competitive Comparison of Acerus Pharmaceuticals's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Acerus Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acerus Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acerus Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Acerus Pharmaceuticals's Days Payable falls into.

Acerus Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Acerus Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (1.394	+	3.933)	/	2 )	/	1.431	*	365
=	2.6635					/	1.431	*	365
=	679.37

Acerus Pharmaceuticals's Days Payable for the quarter that ended in Sep. 2022 is calculated as:

	Days Payable (Q: Sep. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2022 )	+	Accounts Payable (Q: Sep. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2022 )	*	Days in Period
=	( (3.661	+	3.1)	/	2 )	/	0.269	*	365 / 4
=	3.3805					/	0.269	*	365 / 4
=	1,146.73

Acerus Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Acerus Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Acerus Pharmaceuticals (TSX:ASP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8

Website

https://www.aceruspharma.com

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Executives

Norma Beauchamp	Director
Stephen Robert Gregory	Director
Edward Joseph Gudaitis	Director, Senior Officer